Common protein networks for various drug regimens of major depression are associated with complement and immunity
Journal of Psychopharmacology · 2024
DOI: 10.1177/02698811241269683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Psychopharmacology, 2024. Verfasst von Seungyeon Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Senior Healthcare, Graduate School, Eulji University, Uijeongbu, Republic of Korea. Hauptthemen laut MEDLINE: Major Depressive Disorder, Complement System Proteins, Antidepressive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Background
Major depressive disorder (MDD) can present a variety of clinical presentations and has high inter-individual heterogeneity. Multiple studies have suggested various subtype models related to symptoms, etiology, sex, and treatment response. Employing different regimens is common when treating MDD, and identifying effective therapeutics requires time. Frequent treatment attempts and failures can lead to a diagnosis of treatment resistance, and the heterogeneity of treatment responses among individuals makes it difficult to understand and interpret the biological mechanisms underlying MDD.
Aim
This study explored the differentially expressed proteins and commonly altered protein networks across drug treatments by comparing the serum proteomes of patients with MDD treated with drug regimens (T-MDD, n = 20) and untreated patients (NT-MDD, n = 20).
Methods
Differentially expressed proteins were profiled in non-drug-treated and drug-treated patients with depression using liquid chromatography-mass spectrometry. The common protein networks affected by different medications were studied.
Results
Of the proteins profiled, 12 were significantly differentially expressed between the T-MDD and NT-MDD groups. Commonly altered proteins and networks of various drug treatments for depression were related to the complement system and immunity.
Conclusions
Our results provide information on common biological changes across different pharmacological treatments employed for depression and provide an alternative perspective for improving our understanding of the biological mechanisms of drug response in MDD with great heterogeneity in the background of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Senior Healthcare, Graduate School, Eulji University, Uijeongbu, Republic of Korea.
- Department of Biomedical Laboratory Science, College of Health Sciences, Eulji University, Seongnam, Republic of Korea.
- Department of Biomedical Laboratory Science, College of Health Science, Eulji University, Uijeongbu, Republic of Korea.
ORCID-Profile: Jiyeong Lee, Hee-Gyoo Kang
Zitieren
APA
Lee, S., Mun, S., Lee, J., & Kang, H. G. (2024). Common protein networks for various drug regimens of major depression are associated with complement and immunity. Journal of Psychopharmacology. https://doi.org/10.1177/02698811241269683
Vancouver
Lee S, Mun S, Lee J, Kang HG. Common protein networks for various drug regimens of major depression are associated with complement and immunity. Journal of Psychopharmacology. 2024. doi:10.1177/02698811241269683
BibTeX
@article{Lee2024,
author = {Lee, Seungyeon and Mun, Sora and Lee, Jiyeong and Kang, Hee-Gyoo},
title = {Common protein networks for various drug regimens of major depression are associated with complement and immunity},
journal = {Journal of Psychopharmacology},
year = {2024},
doi = {10.1177/02698811241269683}
}
EUVIMED